142 related articles for article (PubMed ID: 1341718)
1. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
Kristensen J; Jonsson B; Sundström C; Nygren P; Larsson R
Med Oncol Tumor Pharmacother; 1992; 9(2):65-74. PubMed ID: 1341718
[TBL] [Abstract][Full Text] [Related]
2. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
Larsson R; Kristensen J; Sandberg C; Nygren P
Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
[TBL] [Abstract][Full Text] [Related]
3. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
Nygren P; Kristensen J; Jonsson B; Sundström C; Lönnerholm G; Kreuger A; Larsson R
Leukemia; 1992 Nov; 6(11):1121-8. PubMed ID: 1434793
[TBL] [Abstract][Full Text] [Related]
5. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
[TBL] [Abstract][Full Text] [Related]
6. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
Fridborg H; Jonsson B; Nygren P; Csoka K; Nilsson K; Oberg G; Kristensen J; Bergh J; Tholander B; Olsen L
Br J Cancer; 1994 Jul; 70(1):11-7. PubMed ID: 8018519
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
Aleskog A; Larsson R; Höglund M; Kristensen J; Nygren P; Lindhagen E
Anticancer Drugs; 2005 Mar; 16(3):277-83. PubMed ID: 15711179
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytotoxic drug activity and in vivo pharmacokinetics in childhood acute myeloid leukemia.
Lönnerholm G; Frost BM; Larsson R; Liliemark E; Nygren P; Peterson C
Adv Exp Med Biol; 1999; 457():429-35. PubMed ID: 10500819
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
Larsson R; Nygren P
Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
[TBL] [Abstract][Full Text] [Related]
10. In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
Larsson R; Fridborg H; Kristensen J; Sundström C; Nygren P
Br J Cancer; 1993 May; 67(5):969-74. PubMed ID: 8494730
[TBL] [Abstract][Full Text] [Related]
11. In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.
Klumper E; Ossenkoppele GJ; Pieters R; Huismans DR; Loonen AH; Rottier A; Westra G; Veerman AJ
Br J Haematol; 1996 Jun; 93(4):903-10. PubMed ID: 8703824
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
Larsson R; Fridborg H; Liliemark J; Csoka K; Kristensen J; de la Torre M; Nygren P
Eur J Cancer; 1994; 30A(7):1022-6. PubMed ID: 7946567
[TBL] [Abstract][Full Text] [Related]
13. In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csóka K; Tholander B; Gerdin E; de la Torre M; Larsson R; Nygren P
Int J Cancer; 1997 Sep; 72(6):1008-12. PubMed ID: 9378534
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
Larsson R; Nygren P; Ekberg M; Slater L
Leukemia; 1990 Aug; 4(8):567-71. PubMed ID: 2388483
[TBL] [Abstract][Full Text] [Related]
15. Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia.
Lindhagen E; Eriksson A; Wickström M; Danielsson K; Grundmark B; Henriksson R; Nygren P; Aleskog A; Larsson R; Höglund M
Eur J Haematol; 2008 Nov; 81(5):344-53. PubMed ID: 18637032
[TBL] [Abstract][Full Text] [Related]
16. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
Nygren P; Hagberg H; Glimelius B; Sundström C; Kristensen J; Christiansen I; Larsson R
Ann Oncol; 1994; 5 Suppl 1():127-31. PubMed ID: 8172809
[TBL] [Abstract][Full Text] [Related]
19. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Nygren P; Larsson R
Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.
Styczynski J; Wysocki M; Dluzniewska A; Juraszewska E; Balwierz W; Czyzewski K; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Stanczak E; Malinowska I; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Kapuscinska L; Szczepanek J; Kolodziej B; Rafinska B; Kubicka M
Anticancer Res; 2008; 28(3B):1927-31. PubMed ID: 18630483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
